Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

BOLD

Boundless Bio (BOLD)

Boundless Bio Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:BOLD
일자시간출처헤드라인심볼기업
2017/10/1107:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/10/1107:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/10/1107:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/10/1107:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/10/1107:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/10/1021:56Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BOLDBoundless Bio Inc
2017/10/0315:00PR Newswire (US)Audentes Therapeutics Announces MHRA Approval of Clinical Trial Authorisation Application for AT132 to Treat X-Linked Myotubu...NASDAQ:BOLDBoundless Bio Inc
2017/09/3007:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/09/3006:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/09/3006:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/09/2721:12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
2017/09/2721:00PR Newswire (US)Audentes Therapeutics Announces Rare Pediatric Disease and Fast Track Designations for AT132 for the Treatment of X-Linked My...NASDAQ:BOLDBoundless Bio Inc
2017/09/2706:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/09/2121:00PR Newswire (US)Audentes Therapeutics Announces Dosing of First Patient in ASPIRO, a Phase 1/2 Clinical Trial of AT132 for the Treatment of X...NASDAQ:BOLDBoundless Bio Inc
2017/09/2007:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/09/2007:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/09/1921:00PR Newswire (US)Audentes Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:BOLDBoundless Bio Inc
2017/09/1203:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/09/0206:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/08/2605:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/08/2419:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BOLDBoundless Bio Inc
2017/08/2223:00Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:BOLDBoundless Bio Inc
2017/08/1105:23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BOLDBoundless Bio Inc
2017/08/1021:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
2017/08/1021:00PR Newswire (US)Audentes Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate UpdateNASDAQ:BOLDBoundless Bio Inc
2017/08/0906:07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:BOLDBoundless Bio Inc
2017/07/1821:00PR Newswire (US)Audentes Therapeutics Announces Appointment of Fulvio Mavilio, Ph.D. to Vice President Scientific Affairs, EuropeNASDAQ:BOLDBoundless Bio Inc
2017/07/1821:00PR Newswire (US)Audentes Therapeutics Announces Appointment of Fulvio Mavilio, Ph.D. to Vice President Scientific Affairs, EuropeNASDAQ:BOLDBoundless Bio Inc
2017/07/1506:18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
2017/06/2905:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
 검색 관련기사 보기:NASDAQ:BOLD